Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

October
30
2017

What is Superficial Radio Therapy? (SRT)

What is Superficial Radio Therapy? Superficial Radio Therapy is the latest non-invasive, non-melanoma skin cancer treatment option. Superficial Radio Therapy is administered with the use of the SRT-100™, our state-of-the-art system inspired by the tried-and-true…

October
25
2017

Sensus Healthcare to Host Third Quarter 2017 Financial Results and Business Update Conference Call on November 2, 2017

BOCA RATON, Fla., Oct. 25, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and keloids with Superficial Radiation Therapy (SRT), announces that management will…

October
24
2017

Non-Melanoma Skin Cancer Treatment Market | Analysis and Key Trends 2025

24 OCTOBER 2017 BY MACIEJ HEYMAN Government initiatives to raise awareness of non-melanoma skin cancer Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it…

October
23
2017

Stratpharma AG & Sensus Healthcare Announce Strategic Collaboration for Transformative Superficial Radiation Therapy & Post-Treatment Care

Collaboration Brings Sensus Healthcare’s SRT Technology and Stratpharma’s Wound Care Medical Devices Together to Advance Radiation Patient Outcomes SAN DIEGO, Oct. 23, 2017 — Stratpharma Inc. USA, a U.S. subsidiary of Stratpharma AG, the Swiss…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy